2022 NIAID Omnibus Broad Agency Announcement
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2022-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Microbiotix, Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93023C00001 Federal contract award
Notice details come from SAM.gov. Updated .
About this opportunity
This cost-reimbursement contract for $14,195,727 was awarded by the National Institute of Allergy and Infectious Diseases to Microbiotix, Inc. on November 1, 2022 to develop inhibitors of pan-filovirus entry and conduct preclinical studies to support an investigational new drug application for the phenylpiperazines series of small molecule inhibitors through lead optimization, selection of a preclinical candidate, and IND-enabling preclinical studies under a full and open competition by the National Institutes of Health's National Institute of Allergy and Infectious Diseases.
Notice text
This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award. This contract is to develop the phenylpiperazines (PPZ) series of small molecule pan-filovirus entry inhibitors through lead optimization, selection of a preclinical candidate, and IND-enabling preclinical studies.
Awarded contract 75N93023C00001 to MICROBIOTIX, INC. for 14195727.00 on 2022-11-01.
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2022 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| 2022 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| 2022 NIAID Omnibus Broad Agency Announcement | Award Notice | |
| This notice | Award Notice | |
| 2022 NIAID Omnibus Broad Agency Announcement | Solicitation | |
| 2022 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity